rs6474414

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000749.5(CHRNB3):​c.53-3524A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.614 in 152,102 control chromosomes in the GnomAD database, including 33,226 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.61 ( 33226 hom., cov: 32)

Consequence

CHRNB3
NM_000749.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.541

Publications

11 publications found
Variant links:
Genes affected
CHRNB3 (HGNC:1963): (cholinergic receptor nicotinic beta 3 subunit) The nicotinic acetylcholine receptors (nAChRs) are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are (hetero)pentamers composed of homologous subunits. The subunits that make up the muscle and neuronal forms of nAChRs are encoded by separate genes and have different primary structure. There are several subtypes of neuronal nAChRs that vary based on which homologous subunits are arranged around the central channel. They are classified as alpha-subunits if, like muscle alpha-1 (MIM 100690), they have a pair of adjacent cysteines as part of the presumed acetylcholine binding site. Subunits lacking these cysteine residues are classified as beta-subunits (Groot Kormelink and Luyten, 1997 [PubMed 9009220]). Elliott et al. (1996) [PubMed 8906617] stated that the proposed structure for each subunit is a conserved N-terminal extracellular domain followed by 3 conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region.[supplied by OMIM, Apr 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.786 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNB3NM_000749.5 linkc.53-3524A>C intron_variant Intron 1 of 5 ENST00000289957.3 NP_000740.1 Q05901
LOC105379396XR_007060900.1 linkn.983T>G non_coding_transcript_exon_variant Exon 2 of 2
CHRNB3NM_001347717.2 linkc.-171+712A>C intron_variant Intron 2 of 6 NP_001334646.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNB3ENST00000289957.3 linkc.53-3524A>C intron_variant Intron 1 of 5 1 NM_000749.5 ENSP00000289957.2 Q05901
CHRNB3ENST00000534391.1 linkc.-171+712A>C intron_variant Intron 2 of 3 3 ENSP00000433913.1 A0A1D5RMT8
CHRNB3ENST00000531610.5 linkn.472+712A>C intron_variant Intron 3 of 3 4

Frequencies

GnomAD3 genomes
AF:
0.614
AC:
93368
AN:
151984
Hom.:
33219
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.227
Gnomad AMI
AF:
0.819
Gnomad AMR
AF:
0.705
Gnomad ASJ
AF:
0.700
Gnomad EAS
AF:
0.806
Gnomad SAS
AF:
0.705
Gnomad FIN
AF:
0.759
Gnomad MID
AF:
0.697
Gnomad NFE
AF:
0.777
Gnomad OTH
AF:
0.646
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.614
AC:
93388
AN:
152102
Hom.:
33226
Cov.:
32
AF XY:
0.620
AC XY:
46081
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.227
AC:
9413
AN:
41494
American (AMR)
AF:
0.705
AC:
10778
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.700
AC:
2424
AN:
3464
East Asian (EAS)
AF:
0.807
AC:
4160
AN:
5158
South Asian (SAS)
AF:
0.706
AC:
3403
AN:
4818
European-Finnish (FIN)
AF:
0.759
AC:
8031
AN:
10576
Middle Eastern (MID)
AF:
0.699
AC:
204
AN:
292
European-Non Finnish (NFE)
AF:
0.777
AC:
52863
AN:
67992
Other (OTH)
AF:
0.647
AC:
1368
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1422
2844
4266
5688
7110
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.728
Hom.:
19359
Bravo
AF:
0.592
Asia WGS
AF:
0.701
AC:
2437
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.46
DANN
Benign
0.57
PhyloP100
-0.54
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6474414; hg19: chr8-42560336; API